Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
Clinical TB lab first to meet enhanced safety review
Original title: “New safety protocols in place, first CDC lab resumes transfer of inactivated materials out of high-containment laboratory - Media Statement”
REQUIRED
Original title: “New TB Screening Guidelines Overseas Save U.S. Estimated $15 Million - Press Release”
Update on Tuberculosis Case in an International Traveler
Original title: “Update on Tuberculosis Case in an International Traveler”
Dr. Julie Gerberding, Director, Dr. Martin Cetron, Director, Division of Global Migration and Quarantine, and Dr. Ken Castro, Director, Division of Tuberculosis Elimination, CDC
Original title: “Telebriefing update on CDC investigation into people potentially exposed to patient with extensively drug-resistant TB”
CDC Press Briefing - 2 p.m. ET TODAY
Original title: “Update on CDC investigation into people potentially exposed to patient with extensively drug-resistant TB”
Tuberculosis rates in the United States reached an all-time low in 2006, though progress to eliminate TB continued to slow. Drug-resistant TB, including extensively drug-resistant TB, presents significant challenges to treatment...
Original title: “U.S. Tuberculosis Cases at All-Time Low; Drug Resistance Remains a Threat”